Skip to main content

Oh, the Places They’ll Go! The ID Fellowship Program (ACGME) Celebrates Graduation

June 26, 2024
The ID Fellowship Program led by Christopher Sellers, MD, MPH, held a reception for six graduating fellows at the Siena Hotel in Chapel Hill, on the evening of June 18. Joined by Joe Eron, MD, chief of the division of infectious diseases, Myron Cohen, MD, director of the Institute for...

ViiV Healthcare Names Two Fellowships Honoring the Late Dr. Adaora Adimora

June 26, 2024
Dr. Adaora Adimora was a distinguished physician-scientist who made exceptional contributions to the fields of HIV epidemiology and clinical care. To continue her legacy of work, ViiV Healthcare will fund two yearly fellowships, co-directed by Myron Cohen, MD, professor of medicine and director of the UNC Institute for Global Health and...

Floris-Moore Delivers the Norma Berryhill Distinguished Lecture, Honoring the Work of Adaora Adimora

June 26, 2024
Michelle Floris-Moore, MD, MPH, professor of medicine and a member of the Institute for Global Health and Infectious Diseases, delivered the 2024 Norma Berryhill Distinguished Lecture on June 20. Her presentation honored the trailblazing work of her mentor, the late Adaora Adimora, who was selected as the 2023 distinguished lecturer...

It’s a Wrap: The 2nd Annual Global Health Scholars Symposium

February 22, 2024
The 2nd Annual Global Health Scholars Symposium took place Friday, Feb. 16, showcasing the impactful work of 43 trainees in the U.S. and around the world. Near and far, approximately 250+ participants came together to share and learn about global health research. Opening Remarks Suzanne Maman, PhD, the associate dean...

Coming Feb. 16: The 2nd Annual Global Health Scholars Symposium 

January 25, 2024
The 2nd Annual Global Health Scholars Symposium is scheduled for Friday, Feb. 16 from 9:15am-12pm! Presented by the UNC Institute for Global Health and Infectious Diseases (IGHID) and the UNC Gillings School of Global Public Health (GSGPH), the symposium will feature global health research from MD/PhD students, doctoral candidates, postdoctoral fellows and...

The Global Fight Against HIV is at Risk

November 2, 2023
Hard-won gains in the long-running global HIV epidemic are in danger of being lost, argues Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP at Columbia University, in a new commentary published today in Science. Co-authored with Myron S. Cohen, MD, director of the Institute for Global Health and Infectious...

Alumni Gift Will Fund New Clinic in Malawi, Enhancing Research and Care for Reproductive Health and Sexually Transmitted Infections

February 20, 2023
A generous gift from Hyman and Marietta Bielsky will fund a new clinic in Malawi for reproductive health and sexually transmitted infections. The new clinic will replace a 50-year-old infrastructure for sexually transmitted disease research and care, the place where UNC’s global health work began.   Long-lived friendships are special connections with those who knew...

Some of the Many Faces of HIV Research: Treatment, Prevention and Pursuing a Cure

December 13, 2022
HIV virus eradication is a complex health challenge due to its long-lived persistence and how it hides in latently infected cells that escape the body’s immune system. Effective HIV treatments have decreased the likelihood of someone developing AIDS, while helping individuals live long and healthy lives without transmission to sexual...

On World AIDS Day: Cohen Reflects On the History of an Incredible Scientific Achievement 40 Years After the Discovery of HIV

December 1, 2022
Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Dr. Myron “Mike” Cohen, director of the UNC Institute for Global Health & Infectious Diseases is the...

Scholars Present During the First Annual Global Health Scholars Symposium

November 20, 2022
The First Annual Global Health Scholars Symposium took place November 11, sponsored by the Institute of Global Health & Infectious Diseases (IGHID) and the Gillings School of Global Public Health (GSGPH). The symposium showcased over 30 investigators from UNC and global sites around the world, featuring MD/PhD students, doctoral candidates, postdoctoral...

UNC Launches Largest COVID-19 Observational Study of its Kind in North Carolina

November 8, 2022
This study led by the UNC Institute for Global Health & Infectious Diseases, will enroll 7,500 COVID-positive individuals to answer some of the biggest questions about COVID-19. Investigators explain the study in this video. Over two years into the COVID-19 pandemic and researchers still are looking to answer some of...

Wrapping Up IGHIDFest! During UNC Research Week

October 19, 2022
A big thanks to everyone who contributed to the success of IGHIDFest! during UNC Research Week. This was the first year that the Institute for Global Health & Infectious Diseases (IGHID) participated in the week long celebration of Carolina’s research and education enterprise. Our follow-up survey confirms what a recent study...

Cohen Featured in NOVA Program “Ending HIV in America” Premiering October 5 at 9 pm on PBS

September 14, 2022
(Note: This post has been updated to reflect a schedule change.) Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Myron “Mike” Cohen, MD, director of...

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 1, 2022
Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through...

NIAID recognizes HPTN’s groundbreaking work in covid prevention tools

June 9, 2022
The 2022 HPTN Annual Meeting took place June 5-8 in Washington, D.C., bringing hundreds of worldwide researchers, collaborators, community representatives, and government health officials together to share updates and accomplishments and re-engage with each other as a community. HPTN Principal Investigators Myron Cohen, MD, director of the UNC Institute for...

Study shows long lasting cabotegravir for the prevention of HIV-1 in women superior to oral treatment

June 7, 2022
In 2021, women and girls in sub-Saharan Africa accounted for three of five new HIV infections, and young women aged 15–24 years were three times as likely as young men in the same age group to be infected with HIV. Despite expanded access to oral PrEP, women are disproportionately affected...

Bamlanivimab reduces risk of COVID in skilled nursing homes and assisted living facilities, study finds

July 21, 2021
UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The...

UNC investigators help prove a monoclonal antibody prevents, treats COVID-19 in nursing homes

January 21, 2021
  Eli Lilly today released results of a clinical trial that found bamlanivimab, a monoclonal antibody, significantly reduced the risk of contracting COVID-19 among residents and staff of long-term care facilities. The Phase 3 trial was conducted in partnership with the NIH’s National Institute of Allergy and Infectious Diseases and...

Current status of COVID-19 vaccine development

December 30, 2020
Presented by Larry Corey, MD Past President and Director, Professor of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine, University of Washington Corey is an internationally renowned expert in virology, immunology and vaccine development. His research focuses on herpes viruses, HIV, the novel...

NIH awards seven-year funding to Cohen and El-Sadr for leadership of HIV Prevention Trials Network

November 30, 2020
AIDS Clinical Trials Group, co-led by UNC’s Joseph Eron, MD, also re-funded for seven years Myron S. Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and Wafaa El-Sadr, MD, MPH, MPA, director of ICAP at Columbia University, have received a seven-year award from the National Institutes...